The Effectiveness Of High-Flow Nasal Cannula (HFNC) Therapy On Improvement Of Oxygen Saturation With Acute Breathing Failure In Covid-19 Patients (Literature Study)

  • Syafruddin Ali Salaka Poltekkes Kemenkes Mamuju
  • Hardiyati . Poltekkes Kemenkes Mamuju
  • Iqra S Poltekkes Kemenkes Mamuju
  • I Made Sudarta Poltekkes Kemenkes Mamuju
Keywords: High-flow nasal cannula (HFNC), Oxygen Saturation, Covid-19


The Covid-19 pandemic has hit the world today, causing a health crisis, a humanitarian crisis and a socio-economic crisis. Covid-19 is classified as SARS-CoV-2 which was first discovered on December 1, 2019 in Wuhan, China. The COVID-19 pandemic has caused an increase in new cases in a short time, resulting in an increase in the use of the necessary supporting facilities and infrastructure. The use of Flow Nasal Cannula (HFNC) is very helpful in increasing oxygen saturation in patients with respiratory failure despite being given oxygen through a 15 liter per minute nasal cannula. Objective: To synthesize literature and research documents that identify the effectiveness of High-flow nasal cannula (HFNC) therapy. On increasing oxygen saturation with acute respiratory failure in Covid-19 patients. Methods: This study uses a literature study whose articles were obtained from 3 databases, namely Google Schoolar, Pub Med, and GARUDA (Garba Reference Digital) indexed from DOAJ (Directory of Open Access Journals) Elsevier, Wiley Online Library, Sinta 3, Scopus, and Springer. Results: The administration of High-flow nasal cannula (HFNC) therapy to increase oxygen saturation with acute respiratory failure in Covid-19 patients was able to have a positive impact on increasing oxygen saturation with acute respiratory failure in Covid-19 patients. Conclusion: There is a significant effect on the administration of High-flow nasal cannula (HFNC) therapy on increasing oxygen saturation with acute respiratory failure in Covid-19 patients.


Download data is not yet available.


Alshahrani,M.S.,Alshaqaq,H.M.,Alhumaid,J.,Binammar,A.A.,AlSalem,K.H., Alghamdi, A., . . . Al Jumaan, M. (2020). High-Flow Nasal Cannula Treatment in Patients with COVID-19 Acute Hypoxemic Respiratory Failure.

Audley,G.,Frankenfeld,P.,Dlamini,S.,Raubenheimer,P.,Hoare,J.,Cairncross, L., . . . Calligaro, G. (2020). Prolonged treatment of COVID-19 pneumonia withhigh-flownasaloxygen:Astoryofoxygenandresilience.SAMJ:South African Medical Journal, 110(10),0-0.

Calligaro, G. L., Lalla, U., Audley, G., Gina, P., Miller, M. G., Mendelson, M., . . . Peter, J. (2020). The utility of high-flow nasal oxygenfor severe COVID-19 pneumonia in a resource-constrained setting: A multi-centre prospective observational study. EClinicalMedicine, 28,100570.

Chandel, A., Patolia, S., Brown, A. W., Collins, A. C., Sahjwani, D., Khangoora, V.,

...Kilcullen,J.K.(2020).High-flownasalcannulainCOVID-19:Outcomes of application and examination of the ROX index to predict success. Respiratorycare.

Demoule, A., Vieillard Baron, A., Darmon, M., Beurton, A., Géri, G., Voiriot, G., . .Labbé, V. (2020). High-flow nasal cannula in critically iii patients with severe COVID-19. American journal of respiratory and critical care medicine, 202(7), 1039-1042

Duan, J., Chen, B., Liu, X., Shu, W., Zhao, W., Li, J., . . . Wang, K. (2020). Use of high-flow nasal cannula and noninvasive ventilation in patients with COVID- 19: A multicenter observational study. The American Journal of Emergency Medicine.

Geng, S., Mei, Q., Zhu, C., Yang, T., Yang, Y., Fang, X., & Pan, A. (2020). High flownasalcannulaisagoodtreatmentoptionforCOVID-19.Heart&Lung: The Journal of Cardiopulmonary and Acute Care, 49(5),444-445.

Hu,M.,Zhou,Q.,Zheng,R.,Li,X.,Ling,J.,Chen,Y.,...Xie,C.(2020).Application of high-flow nasal cannula in hypoxemic patients with COVID-19: a retrospective cohort study. BMC pulmonary medicine, 20(1),1-7.

Istanto, W., & Tua, E. M. (2020). Manajemen Perioperatif pada Pasien COVID-19. Medica Hospitalia: Journal of Clinical Medicine, 7(1A), 214-225.

Satgas,P.C.-(2021).PetaSebaranCovid-19DiIndonesia.Diaksespadatanggal 30 maret 2021, ukul 09.00 WITA dari covid19

SulBar,D.K.P.(2021).DataPantauanCovid-19diSulawesiBarat.Diaksespada tanggal 30 maret 2021, pukul 11.00 WITA dari https://dinkes.sulbarprov.

Teng, X. b., Shen, Y., Han, M. f., Yang, G., Zha, L., & Shi, J. f. (2020). The value of high‐flow nasal cannula oxygen therapy in treating novel coronavirus pneumonia. European Journal of Clinical Investigation, 51(3), e13435.

Vianello, A., Arcaro, G., Molena, B., Turato, C., Sukthi, A., Guarnieri, G., . . . Navalesi, P. (2020). High-flow nasal cannula oxygen therapy to treat patients with hypoxemic acute respiratory failure consequent to SARS- CoV-2 infection. Thorax, 75(11), 998-1000.

Wang, K., Zhao, W., Li, J., Shu, W., & Duan, J. (2020). The experience of high- flow nasal cannula in hospitalized patients with 2019 novel coronavirus- infected pneumonia in two hospitals of Chongqing, China. Annals of intensive care, 10, 1-5.

WHO. (2021). Coronavirus disease (COVID-19) Situation. Di akses pada tanggal 30 maret 2021, pukul 13.00 WITA dari

Wu, C.-N., Xia, L.-Z., Li, K.-H., Ma, W.-H., Yu, D.-N., Qu, B., . . . Cao, Y. (2020).High-flow nasal-oxygenation-assisted fibreoptic tracheal intubation in critically ill patients with COVID-19 pneumonia: a prospective randomised controlled trial. British journal of anaesthesia, 125(1), e166-e168.

How to Cite
Salaka, S., ., H., S, I., & Sudarta, I. M. (2022). The Effectiveness Of High-Flow Nasal Cannula (HFNC) Therapy On Improvement Of Oxygen Saturation With Acute Breathing Failure In Covid-19 Patients (Literature Study). JURNAL KEPERAWATAN DAN FISIOTERAPI (JKF), 4(2), 237-247.